Interleukin-6 Receptor Antagonist
6 drugs across 3 manufacturers|0 Generic,6 Brand
Total Drugs
6
0G / 6B
Manufacturers
3
Avg $1344.9831/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
6 flat
of 6 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
3 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KEVZARA 200 MG/1.14 ML PEN INJ sarilumab | $2079.8200 per ML | — |
KEVZARA 200 MG/1.14 ML SYRINGE sarilumab | $2066.4821 per ML | — |
ACTEMRA ACTPEN 162 MG/0.9 ML tocilizumab | $1279.0578 per ML | — |
ACTEMRA 162 MG/0.9 ML SYRINGE tocilizumab | $1001.1205 per ML | — |
TYENNE 162 MG/0.9 ML AUTOINJCT Tocilizumab-aazg | $821.7093 per ML | — |
TYENNE 162 MG/0.9 ML AUTOINJCT Tocilizumab-aazg | $821.7093 per ML | — |